Opus Genetics, Inc. Common Stock IRD

$5.73 +32.03% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-09-09 View →
4 FORM 4 2026-09-08 View →
4 FORM 4 2026-09-08 View →
S-3 S-3 2026-08-07 View →
10-Q 10-Q 2026-08-06 View →
8-K 8-K 2026-08-06 View →
4 FORM 4 2026-07-27 View →
4 FORM 4 2026-07-27 View →
4 FORM 4 2026-07-27 View →
4 FORM 4 2026-07-27 View →
8-K 8-K 2026-06-16 View →
8-K 8-K 2026-06-16 View →
S-3 S-3 2026-06-05 View →
4 PRIMARY DOCUMENT 2026-05-20 View →
10-Q 10-Q 2026-05-12 View →
8-K 8-K 2026-05-12 View →
4 FORM 4 2026-04-27 View →
4 FORM 4 2026-04-27 View →
4 FORM 4 2026-04-27 View →
4 FORM 4 2026-04-27 View →
4 FORM 4 2026-04-27 View →
4 FORM 4 2026-04-27 View →
8-K 8-K 2026-04-24 View →
4 FORM 4 2026-04-22 View →
4 FORM 4 2026-04-22 View →
4 FORM 4 2026-04-22 View →
4 FORM 4 2026-04-22 View →
4 FORM 4 2026-04-22 View →
4 FORM 4 2026-04-22 View →
4 FORM 4 2026-04-22 View →
8-K 8-K 2026-04-22 View →
8-K 8-K 2026-04-07 View →
8-K 8-K 2026-04-07 View →
DEF 14A DEF 14A 2026-03-23 View →
4 FORM 4 2026-03-18 View →
4 FORM 4 2026-03-18 View →
4 FORM 4 2026-03-18 View →
4 FORM 4 2026-03-18 View →
S-3 S-3 2026-03-13 View →
10-K 10-K 2026-03-12 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$5.73
Market Cap
$361.07 million
52-Week Range
$1.04 – $7.07
Average Volume
2.98 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.